Support us
Ton Schumacher group leader
Ton Schumacher

Ton Schumacher

Group leader

Email

Ton Schumacher performed his Ph.D. research from 1988-1992 at The Netherlands Cancer Institute where he studied the interactions of MHC class I molecules with antigenic peptides in the laboratory of Hidde Ploegh. After a brief stint as a post-doc in the laboratory of Hidde Ploegh at the Massachusetts Institute of Technology, he joined the group of Peter Kim at the Whitehead Institute in Cambridge, USA in 1994.

In 1996 he joined The Netherlands Cancer Institute, where he is currently Senior Member, to study the development of T cell immunity through biotechnological approaches. Schumacher is recipient of, amongst others, The Amsterdam Inventor Award, Queen Wilhelmina Cancer Research Award, Meyenburg Cancer Research Award, William B. Coley Award, and Stevin Prize. Next to his position at The Netherlands Cancer Institute, Schumacher is involved in the development of novel immunotherapeutics in biotech and in venture capital.


Fields of expertise

Cancer Immunology

Cancer Immunotherapy

T cell immunity

Work experience

2018-present
Venture partner, Third Rock Ventures

2015-2018
CSO, Kite Pharma EU

2012-2016
Deputy Director, The Netherlands Cancer Institute

2005-present
Professor of Immunotechnology, Leiden University Medical Center, Leiden

2002-present
Full Member, Department of Immunology, The Netherlands Cancer Institute, Amsterdam

2001-2002
Associate Member, Department of Immunology, The Netherlands Cancer Institute, Amsterdam

1996-2001
Assistant Member, Department of Immunology, The Netherlands Cancer Institute, Amsterdam

1994-1996
Postdoctoral Associate, The Whitehead Institute for Biomedical Research, MIT, Cambridge

1992-1994
Postdoctoral Fellow, Center for Cancer Research, MIT, Cambridge

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.